SYNLAB delivers record growth in Q1 2021
Search jobs
DGAP-News: SYNLAB AG / Key word(s): Quarter Results
12.05.2021 / 07:30
SYNLAB delivers record growth in Q1 2021
- Nearly doubling revenue (+96%) in Q1 21 at EUR 938 million
- Strong SARS-CoV-2 testing volumes in Q1 21, above Q4 20
- Sustained underlying organic growth
- Adjusted EBITDA multiplied by 3.8x at EUR 324 million, margin showing strong volume leverage
- Record unlevered FCF of EUR 182 million driving major leverage ratio reduction at 2.3x, pre-IPO
- M&A activity resuming, with 10 acquisitions completed year-to-date (~EUR 44 million of EV)
- Successful IPO, with EUR 400 million raised to further reduce leverage
Disclaimer
This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of shares of SYNLAB AG (the Company ) in the United States.